| ²é¿´: 637 | »Ø¸´: 0 | |||
Üç²Ý¿ÆÐ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇëÎÊsurrogate matricesºÍsurrogate analytesÊÇʲôÒâ˼£¿
|
|
×î½ü¿´ÎÄÏ×£¬LC/MSµÄÓ¦ÓÃÀï×ÜÊÇÌáµ½surrogate matrices£¬ÇëÎÊÕâÊÇʲôÒâ˼£¿ËµÊÇÓÃÀ´½â¾öÄÚÔ´ÐÔ±ê¼ÇÎïµÄÎÊÌ⣿ The survey also showed that members use surrogate matrices, surrogate analytes, standard addition and/or other approaches to overcome the inherent problem of endogenous levels for biomarker assays. |
» ²ÂÄãϲ»¶
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ18È˻ظ´
»ù½ðϵͳʲôÄÚÈÝҲûÓÐ
ÒѾÓÐ6È˻ظ´
¹ú×ÔÈ»ÃæÉϸ´ÅÌ~»¶ÓÌÖÂÛ
ÒѾÓÐ12È˻ظ´
Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ
ÒѾÓÐ9È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8O5.5.1.O5.4,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ3È˻ظ´
ÄÄλ¸ßÈËÖÐÁË£¬°Ñ²éѯµ½µÄ½ØÍ¼Ìù³öÀ´ÈÃÎÒ¿´¿´£¬ÈÃÎÒ³¤³¤¼ûʶ
ÒѾÓÐ6È˻ظ´
ÊÛSCIÎÄÕ£¬ÎÒ:8O5.5.1.O.54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÃæÉϺÏ×÷µ¥Î»¸ÇÕÂ
ÒѾÓÐ5È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ7È˻ظ´
ÉêÇëɾ³ý±¾Ìû
ÒѾÓÐ7È˻ظ´









»Ø¸´´ËÂ¥
ͶƱ: